Johnson & Johnson to Resume European Union Vaccine Rollout With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh the rare risk of blood clots. https://ift.tt/eA8V8J https://www.nytimes.com

on
With the Johnson & Johnson vaccine paused in the United States, the European Union drug regulator found that the benefits outweigh the rare risk of blood clots.

from NYT > Top Stories https://ift.tt/3eyk6On
via IFTTT

Comments

Post a Comment